IP Library › Granted Patent US 12,123,845
Granted Patent B2
US 12,123,845 · App. 17/522,421 · Granted Oct 22, 2024

Two-dimensional-material-based field-effect transistor for detection of pathogens and methods for manufacturing

Inventors: Masoud Mahjouri-Samani (Auburn, AL); Michael C. Hamilton (Auburn, AL); Marcelo Kuroda (Auburn, AL); Sahar Hasim (Macon, GA); Parvin Fathi-Hafshejani (Auburn, AL)
Assignees: AUBURN UNIVERSITY; MERCER UNIVERSITY
G01N27/4145
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,123,845
App. No.
17/522,421
Granted
Oct 22, 2024
Kind
B2
Abstract

In at least one illustrative embodiment, a field-effect transistor biosensor for detection of a pathogen includes a substrate and a channel formed from a two-dimensional monolayer or few-layer metal chalcogenide that is functionalized with a biorecognition element. The biorecognition element may be an antibody, such as an antibody for the SARS-CoV-2 spike protein. A method for manufacturing the biosensor includes depositing an amorphous two-dimensional material on the substrate with pulsed laser ablation, crystallizing the amorphous two-dimensional material to generate a two-dimensional monolayer coupled to the substrate, and activating a surface of the two-dimensional material with the biorecognition element after crystallizing the amorphous two-dimensional material. The composition of the two-dimensional material may be tuned. The substrate may be photolithographically patterned. Other embodiments are described and claimed.

Claims (22)

1. A method for manufacturing a field-effect transistor biosensor to detect pathogens in a sample, the method comprising:

depositing an amorphous two-dimensional material on a substrate with pulsed laser ablation;

crystallizing the amorphous two-dimensional material to generate a two-dimensional monolayer or few-layer coupled to the substrate; and

activating a surface of the two-dimensional material with a biorecognition element for pathogen detection after crystallizing the amorphous two-dimensional material.

2. The method of claim 1 , wherein:

depositing the amorphous two-dimensional material comprises depositing the amorphous two-dimensional material at ambient temperature; and

crystallizing the amorphous two-dimensional material comprises crystallizing the amorphous two-dimensional material with a thermal oven.

3. The method of claim 2 , wherein depositing the amorphous two-dimensional material at ambient temperature comprises depositing the amorphous two-dimensional material at an operating temperature below 150° C.

4. The method of claim 1 , wherein the two-dimensional material comprises a compositionally tunable transition metal dichalcogenide.

5. The method of claim 4 , wherein the transition metal dichalcogenide has a composition of MX 1.5-2 .

6. The method of claim 1 , wherein the two-dimensional material comprises a tunable metal monochalcogenide.

7. The method of claim 6 , wherein the metal monochalcogenide has a composition of MX 0.75-1 .

8. The method of claim 1 , wherein depositing the amorphous two-dimensional material on the substrate with pulsed laser ablation comprises controlling a number of laser pulses to determine a thickness of the amorphous two-dimensional material.

9. The method of claim 1 , further comprising photolithographically patterning the substrate with a device feature to generate a patterned substrate.

10. The method of claim 9 , wherein depositing the amorphous two-dimensional material comprises depositing the amorphous two-dimensional material after patterning the substrate on the patterned substrate.

11. The method of claim 9 , wherein patterning the substrate comprises patterning the substrate after crystallizing the amorphous two-dimensional material.

12. The method of claim 1 , further comprising depositing a source electrode and a drain electrode on the two-dimensional monolayer or few-layer.

13. The method of claim 1 , further comprising applying a source electrode and a drain electrode to the substrate, wherein depositing the amorphous two-dimensional material comprises depositing the amorphous two-dimensional material on the source electrode or the drain electrode.

14. The method of claim 1 , wherein activating the surface of the two-dimensional material with the biorecognition element comprises:

attaching a chemical linker to the surface of the two-dimensional material, wherein the chemical linker comprises 11-mercaptoundecanoic acid;

activating the chemical linker after attaching the chemical linker to the surface; and

attaching the biorecognition element after activating the chemical linker.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2022
From: MAHJOURI-SAMANI, MASOUD; HAMILTON, MICHAEL C.; KURODA, MARCELO A.; FATHI-HAFSHEJANI, PARVIN
To: AUBURN UNIVERSITY
Reel/Frame 059372/0024 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2022
From: HASIM, SAHAR
To: MERCER UNIVERSITY
Reel/Frame 059372/0086 →
Continuity (3)
Provisional Application 63245444 · Sep 17, 2021
Provisional Application 63111892 · Nov 10, 2020
Related Publication 20220146451A1 · May 12, 2022
Cited By (5)
US 12,599,988 US 12,606,896 US 12,611,732 US 12,622,239 US 12,654,197